CLOs on the Move

Bayer Healthcare

www.bayerhealthcare.com

 
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical
  • Number of Employees: 5K-10K
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details

Similar Companies

DaVita Rx

DaVita RxⓇ is the first and largest full-service pharmacy created specifically for the unique needs of kidney patients, and has expanded to other complex conditions as well. We make it easier for patients to get their medications and follow their drug regimens. We give providers a whole new way to improve patient care.

AstraZeneca Pharmaceuticals LP

AstraZeneca Pharmaceuticals LP is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vera Therapeutics

Vera Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera`s lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. In addition, Vera is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove medically useful, including lupus nephritis, a severe renal manifestation of systemic lupus erythematosus.

Bradford Health Services

Its never easy to admit that you or someone you care about is addicted to alcohol or drugs. But once you recognize the problem, the road to recovery appears at your feet. The first step down that road is to find professional help.

Oncology Pharma

Oncology Pharma, Inc. is a pioneering oncology company dedicated to licensing, developing, manufacturing and commercializing therapeutics. The company has assembled a team of executives and advisors with proven multi-disciplinary expertise in the field of oncology, therapeutics and leadership to identify, negotiate and amalgamate “best in class” research, technologies, therapeutics and delivery mechanisms that are synergistic and collaborative. The goal is to create value, reduce costs and increase the speed of regulatory approval and commercialization of effective and safer cancer drugs.